Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
105.25%
-
Total 13F principal
-
$286,734,934
-
Principal change
-
+$268,934,934
-
Total reported market value
-
$302,235,529
-
Number of holders
-
31
-
Value change
-
+$283,279,529
-
Number of buys
-
30
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q1 2014
As of 31 Mar 2014,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
31 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$286,734,934
in principal (par value) of the bond.
The largest 10 bondholders included
EDELMAN FINANCIAL GROUP INC., UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, ADVENT CAPITAL MANAGEMENT /DE/, OSTERWEIS CAPITAL MANAGEMENT INC, AMERIPRISE FINANCIAL INC, ZAZOVE ASSOCIATES LLC, PIONEER INVESTMENT MANAGEMENT INC, WOLVERINE ASSET MANAGEMENT LLC, SILVERBACK ASSET MANAGEMENT LLC, and HIGHBRIDGE CAPITAL MANAGEMENT LLC.
This page lists
31
institutional bondholders reporting positions
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.